TGFB1 and neoplasm: In summary, TGF-β1, IL-10 and IL-35 act directly on immune cells, leading to either suppression of anti-tumor immune cells or enhancement of immunosuppressive cells; whereas IL-6, TNF-α and CXCL8 play important roles in the activation of immune checkpoints, which is important for immunotherapy tolerance.